CITIGROUP INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,073,857
-23.2%
338,756
+20.4%
0.00%0.0%
Q2 2023$1,398,379
-49.0%
281,364
-49.3%
0.00%
-50.0%
Q1 2023$2,743,394
+26.7%
555,343
+61.3%
0.00%0.0%
Q4 2022$2,166,094
-61.3%
344,371
-33.5%
0.00%
-50.0%
Q3 2022$5,592,000
+103.6%
517,789
+114.9%
0.00%
+100.0%
Q2 2022$2,747,000
+152.9%
240,965
+102.2%
0.00%
+100.0%
Q1 2022$1,086,000
-72.6%
119,165
-55.1%
0.00%
-50.0%
Q4 2021$3,959,000
+21.6%
265,384
+109.5%
0.00%0.0%
Q3 2021$3,255,000
-37.1%
126,655
-36.1%
0.00%
-33.3%
Q2 2021$5,171,000
+18.2%
198,288
+60.0%
0.00%0.0%
Q1 2021$4,376,000
+667.7%
123,961
+449.2%
0.00%
Q4 2020$570,000
+40.4%
22,571
+109.7%
0.00%
Q3 2020$406,000
-81.0%
10,765
-78.4%
0.00%
-100.0%
Q2 2020$2,136,000
+140.8%
49,870
+9.3%
0.00%
+100.0%
Q1 2020$887,000
-24.3%
45,616
+1.1%
0.00%0.0%
Q4 2019$1,172,000
+1.5%
45,112
+6.4%
0.00%0.0%
Q3 2019$1,155,000
-53.8%
42,379
-54.5%
0.00%
-50.0%
Q2 2019$2,502,000
+2133.9%
93,169
+2298.2%
0.00%
Q1 2019$112,000
-26.3%
3,885
-31.0%
0.00%
Q4 2018$152,0005,6320.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders